Public and participant involvement

The MAMA Study has been co-developed with several groups of women who contribute to the trial as lived experience advisors on our MAMA Patient and Public Advisory Group (PAG) and as Patient and Public Involvement (PPI) Co-applicants and Trial Steering Committee members. This has included input to the design and ongoing running of the trial including: co-application to NIHR, input to trial methodology, documents and materials, and participation at investigator meetings. These groups remain involved in the trial, and will continue to do so until the MAMA trial ends.

You can find out more about public involvement at the NPEU Clinical Trials Unit on the Public Involvement in Clinical Trials page.